<Suppliers Price>

PD128907 HCl

Names

[ CAS No. ]:
112960-16-4

[ Name ]:
PD128907 HCl

[Synonym ]:
(+)-(4aR,10bR)-3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol hydrochloride
S(+)-PD 128,907 hydrochloride
PD 125,530
R(-)-PD 128,908 hydrochloride
S(+)-(4aR,10bR)-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol hydrochloride
(+)-PD 128,907 hydrochloride

Biological Activity

[Description]:

PD 128907 (hydrochloride) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

[Related Catalog]:

Research Areas >> Others
Signaling Pathways >> Others >> Others

[In Vitro]

PD128907 hydrochloride 是一种有效的选择性多巴胺 D3 受体激动剂,EC50 为 0.64 nM,比多巴胺 D2 受体选择性高 53 倍。

Chemical & Physical Properties

[ Melting Point ]:
145-153°C

[ Molecular Formula ]:
C14H20ClNO3

[ Molecular Weight ]:
285.77

[ Exact Mass ]:
285.11300

[ PSA ]:
41.93000

[ LogP ]:
2.67640

[ Appearance of Characters ]:
white

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
H2O: >5mg/mL

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ RIDADR ]:
NONH for all modes of transport

Articles

Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

J. Pharmacol. Exp. Ther. 275 , 1355, (1995)

The present study determined the biochemical and pharmacological effects of PD 128907 [R-(+)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H- [1]benzopyrano[4,3-b]-1,4-oxazin-9-ol], a dopamine (DA) recepto...

Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers.

J. Med. Chem. 33 , 445-450, (1990)

The dopamine agonist profile of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol (16a) and its enantiomers (16b-c) was examined. Racemic 16a exhibited moderate af...

Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo.

J. Neurochem. 66 , 2209, (1996)

In freely moving rats, the novel, selective dopamine (DA) D3 receptor agonist PD 128,907 dose-dependently [effective dose (ED25) = 0.07 mg/kg, s.c.] reduced dialysate levels of DA in the frontal corte...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.